Literature DB >> 16402125

Drug metabolism and pharmacogenetics: the British contribution to fields of international significance.

John Caldwell1.   

Abstract

The branch of pharmacology we now call 'drug metabolism', the consideration of the enzymes and procesess determining the disposition of drugs in the body, emerged in the 1840s on the continent of Europe, but British science made little or no contribution until the 1920s. From this point on, the development of the field through the 20th century was shaped to a very significant extent by a series of influential British workers, whose contributions were of global significance and who can now be seen as fathers of the subject. Since the 1950s, and gaining pace inexorably from the 1970s, the significance of drug metabolism to human therapeutics has been greatly added to by the emergence of pharmacogenetics, clinically important hereditary variation in response to drugs, which underpins the current emphasis on personalised medicine. This review examines the British contributions to both these fields through the lives of seven key contributors and attempts to place their work both in the context of its time and its lasting influence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402125      PMCID: PMC1760745          DOI: 10.1038/sj.bjp.0706466

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  The legacy of pharmacogenetics and potential applications.

Authors:  W W Weber
Journal:  Mutat Res       Date:  2001-08-08       Impact factor: 2.433

2.  The formation of mercapturic acids. 2. The possible role of glutathionase.

Authors:  H G BRAY; T J FRANKLIN; S P JAMES
Journal:  Biochem J       Date:  1959-04       Impact factor: 3.857

3.  The formation of mercapturic acids. 3. N-Acetylation of S-substituted cysteines in the rabbit, rat and guinea pig.

Authors:  H G BRAY; T J FRANKLIN; S P JAMES
Journal:  Biochem J       Date:  1959-11       Impact factor: 3.857

4.  Uridine compounds in glucuronic acid metabolism. I. The formation of glucuronides in liver suspensions.

Authors:  G J DUTTON; I D STOREY
Journal:  Biochem J       Date:  1954-06       Impact factor: 3.857

Review 5.  Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.

Authors:  J R Idle; R L Smith
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

6.  On an Autoxidisable Constituent of the Cell.

Authors:  F G Hopkins
Journal:  Biochem J       Date:  1921       Impact factor: 3.857

Review 7.  The metabolism of foreign compounds and the induction of cancer.

Authors:  E Boyland
Journal:  Xenobiotica       Date:  1986 Oct-Nov       Impact factor: 1.908

8.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

9.  The formation of mercapturic acids. 1. Formation of mercapturic acid and the levels of glutathione in tissues.

Authors:  M M BARNES; S P JAMES; P B WOOD
Journal:  Biochem J       Date:  1959-04       Impact factor: 3.857

10.  The metabolic fate of amphetamine in man and other species.

Authors:  L G Dring; R L Smith; R T Williams
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

View more
  3 in total

1.  Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States.

Authors:  John E Murphy; James S Green; Laura A Adams; Robert B Squire; Grace M Kuo; Alan McKay
Journal:  Am J Pharm Educ       Date:  2010-02-10       Impact factor: 2.047

Review 2.  Personalized nanomedicine advancements for stem cell tracking.

Authors:  Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Adv Drug Deliv Rev       Date:  2012-07-20       Impact factor: 15.470

Review 3.  Filling and mining the reactive metabolite target protein database.

Authors:  Robert P Hanzlik; Jianwen Fang; Yakov M Koen
Journal:  Chem Biol Interact       Date:  2008-09-06       Impact factor: 5.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.